Day: January 22, 2020

Communiqué de presse – Information réglementéeÉtude de Phase III évaluant JTA-004 chez des patients souffrant d’arthrose du genou prête pour recrutement des patients début 2020Soumission de la demande d’essai clinique pour la Phase IIb évaluant ALLOB chez des patients présentant des fractures difficiles du tibiaDonnées de suivi à deux ans de l’étude de Phase IIa, pour ALLOB dans la fusion vertébrale, attendues au S2 2020Consommation nette de trésorerie pour l’ensemble de l’année 2019 inférieure aux prévisionsGosselies, Belgique, 22 janvier 2020, 7h00 CET – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée...

COPENHAGEN, Denmark, January 22, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that the sale of its Priority Review Voucher (PRV) has received antitrust clearance. The transaction, which was announced on December 17, 2019 will now proceed towards closing, expected by end of January 2020.For more information about the PRV sale, see company announcement no. 27/2019.About Bavarian NordicBavarian Nordic is a fully integrated biotechnology company focused on the development, manufacture and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and has been a long-term supplier to the U.S. Strategic National Stockpile of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against monkeypox. Our commercial product portfolio furthermore contains...

KØBENHAVN, Danmark, 22. januar 2020 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at salget af dets Priority Review Voucher (PRV) er blevet godkendt af konkurrencemyndighederne. Transaktionen, der blev annonceret den 17. december 2019, vil nu fortsætte mod endelig gennemførelse (closing), der forventes at finde sted inden udgangen af januar 2020.For yderligere informationer om transaktionen henvises til selskabsmeddelelse nr. 27/2019.Om Bavarian NordicBavarian Nordic er et fuldt integreret biotekselskab, der er fokuseret på udvikling, produktion og kommercialisering af livsvigtige vacciner. Vi er globalt førende inden for koppevacciner, og er mangeårig leverandør til det amerikanske strategiske nationale beredskabslager af en ikke-replikerende koppevaccine, som er godkendt af de...

TORONTO, Jan. 21, 2020 (GLOBE NEWSWIRE) — Faircourt Asset Management Inc., as Manager of the Faircourt Funds (NEO:FGX), (NEO:FCS.UN), is pleased to announce the monthly distributions payable on the Shares and Trust Units of the below listed Funds.      Faircourt Asset Management Inc. is the Investment Advisor for Faircourt Gold Income Corp. and Faircourt Split Trust. This press release is not for distribution in the United States or over United States wire services.For further information on the Faircourt Funds, please visit www.faircourtassetmgt.com orplease contact 1-800-831-0304.You will usually pay brokerage fees to your dealer if you purchase or sell Units of the Trust on the NEO Exchange or other alternative Canadian trading system (an “exchange”). If the Units are purchased or sold on...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Reference is made to the stock exchange announcement by PGS ASA (“PGS” or the “Company”) on 21 January 2020 regarding a contemplated private placement (the “Private Placement“) of new shares.The bookbuilding for the Private Placement has been successfully completed, raising gross proceeds of NOK 849,999,960 (corresponding to approximately USD 95 million based on a currency exchange rate of USD/NOK 8.9477), through the allocation of 48,627,000 new shares in the Company...

HOUSTON, Jan. 21, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (Nasdaq:LGIH) today announced the grand opening of its newest community near Houston, Vacek Country Meadows, located in the popular Richmond-Rosenberg area. With convenient access to I-69, US-90 and TX-99, Vacek Country Meadows offers an affordable option for homebuyers seeking new construction and relaxed living within reach of the abundant employment and amenities offered on Houston’s west side.“We are excited to be building in Fort Bend County again,” said Brian Batten, LGI Homes’ Houston Division President.  “Development in this area is booming, and the demand for homeownership is extremely high. LGI offers a simplified buying process and competitive pricing, which we believe buyers in this market will appreciate.”At Vacek Country...

In the light of recent news from Boeing on the ongoing process in cooperation with international aviation authorities of returning the Boeing 737-MAX aircraft safely back to service, Icelandair does not expect the MAX in operation within its route network during the high season of next summer. This will have a minimal impact on Icelandair’s flight schedule 2020 as it was set up with the aim to minimize the impact of a possible further delay in the lifting of the MAX suspension. In addition, the Company has already entered into leasing agreements regarding three Boeing 737-800 aircraft and a decision has been made to keep more Boeing 757 aircraft in operation in 2020 than originally planned.The financial impact of this further suspension will be considerably less this year than in 2019. In addition to the above-mentioned mitigating...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTIONLONDON, Jan. 21, 2020 (GLOBE NEWSWIRE) — Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) announced today that it intends to offer US$110 million of American Depositary Shares (“ADSs”), each representing five ordinary shares, par value US$0.10 each of Chi-Med, on the Nasdaq Global Select Market (“Offering”). Chi-Med intends to grant the underwriters a 30-day option to purchase up to an aggregate of US$16.5 million of additional ADSs at the public offering price, less underwriting discounts and commissions. The Offering is subject to market and other conditions, and there can be no assurance as to...